{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Ironwood Pharmaceuticals, Inc."},"Symbol":{"label":"Symbol","value":"IRWD"},"Address":{"label":"Address","value":"100 SUMMER STREET,SUITE 2300, BOSTON, Massachusetts, 02110, United States"},"Phone":{"label":"Phone","value":"+1 617 621-7722"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities."},"CompanyUrl":{"label":"Company Url","value":"https://www.ironwoodpharma.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Marcel Moulaison","title":"Vice President-Technical Operations"},{"name":"Michael Shetzline","title":"Chief Medical Officer, Senior VP, Head-R&D"},{"name":"Thomas A. McCourt","title":"President, Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}